Bole Tian

700 total citations
33 papers, 483 citations indexed

About

Bole Tian is a scholar working on Oncology, Surgery and Epidemiology. According to data from OpenAlex, Bole Tian has authored 33 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 15 papers in Surgery and 10 papers in Epidemiology. Recurrent topics in Bole Tian's work include Pancreatic and Hepatic Oncology Research (11 papers), Neuroendocrine Tumor Research Advances (9 papers) and Neuroblastoma Research and Treatments (6 papers). Bole Tian is often cited by papers focused on Pancreatic and Hepatic Oncology Research (11 papers), Neuroendocrine Tumor Research Advances (9 papers) and Neuroblastoma Research and Treatments (6 papers). Bole Tian collaborates with scholars based in China, United States and Canada. Bole Tian's co-authors include Zhaoda Zhang, Weiguo Wang, Sirong He, Nengwen Ke, Min Yang, Yi Zhang, Xu-Bao Liu, Anping Su, Yi Zhang and Li Wang and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Biomaterials.

In The Last Decade

Bole Tian

30 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bole Tian China 14 224 171 154 140 124 33 483
Emily Siegel United States 7 167 0.7× 113 0.7× 78 0.5× 46 0.3× 92 0.7× 13 377
Yue Xie China 15 97 0.4× 360 2.1× 69 0.4× 129 0.9× 219 1.8× 27 603
Kristen D. Hadfield United Kingdom 8 117 0.5× 232 1.4× 121 0.8× 56 0.4× 105 0.8× 11 514
Shi‐He Liu United States 14 116 0.5× 219 1.3× 55 0.4× 115 0.8× 77 0.6× 26 394
Leandro M. Colli Brazil 15 170 0.8× 264 1.5× 60 0.4× 144 1.0× 139 1.1× 35 689
Kirsty R. Greenow United Kingdom 9 105 0.5× 185 1.1× 35 0.2× 100 0.7× 74 0.6× 13 383
Wenjing Yang China 12 115 0.5× 214 1.3× 58 0.4× 43 0.3× 127 1.0× 17 414
Hiroto Niizeki Japan 5 117 0.5× 229 1.3× 40 0.3× 57 0.4× 281 2.3× 12 433
Leizhou Xia China 11 117 0.5× 231 1.4× 44 0.3× 80 0.6× 63 0.5× 21 430
Ferdous M. Barlaskar United States 8 122 0.5× 258 1.5× 45 0.3× 297 2.1× 260 2.1× 10 697

Countries citing papers authored by Bole Tian

Since Specialization
Citations

This map shows the geographic impact of Bole Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bole Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bole Tian more than expected).

Fields of papers citing papers by Bole Tian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bole Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bole Tian. The network helps show where Bole Tian may publish in the future.

Co-authorship network of co-authors of Bole Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Bole Tian. A scholar is included among the top collaborators of Bole Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bole Tian. Bole Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Yinggang, Gang Xu, Ning Xia, et al.. (2024). Targeting lipid metabolism via nanomedicine: A prospective strategy for cancer therapy. Biomaterials. 317. 123022–123022. 7 indexed citations
3.
Wu, Chao, et al.. (2022). Potential core genes associated with COVID-19 identified via weighted gene co-expression network analysis. Swiss Medical Weekly. 152(4748). 40033–40033. 2 indexed citations
4.
Wu, Chao, Xing Huang, Li Mao, et al.. (2022). Crosstalk Between Circrnas and the PI3K/AKT and/or MEK/ERK Signaling Pathways in Digestive Tract Malignancy Progression. Future Oncology. 18(40). 4525–4538. 5 indexed citations
5.
6.
Yang, Min, Nengwen Ke, Chunlu Tan, et al.. (2020). World Health Organization grading classification for pancreatic neuroendocrine neoplasms: a comprehensive analysis from a large Chinese institution. BMC Cancer. 20(1). 906–906. 21 indexed citations
7.
8.
Li, Pei-Wen, et al.. (2019). A novel gemcitabine derivative-loaded liposome with great pancreas-targeting ability. Acta Pharmacologica Sinica. 40(11). 1448–1456. 24 indexed citations
9.
10.
Yang, Min, Nengwen Ke, Yi Zhang, et al.. (2017). Functional and non-functional pancreatic neuroendocrine tumours: ENETS or AJCC TNM staging system?. Oncotarget. 8(47). 82784–82795. 12 indexed citations
11.
Wang, Weiguo, Yi Zhang, Li Wang, Yang Chen, & Bole Tian. (2015). Chronic pancreatic inflammatory granuloma caused by foreign body presenting as a pancreatic pseudotumor: A case report and literature review. Pancreatology. 15(5). 573–575. 2 indexed citations
12.
Yang, Min, Yi Zhang, Weiguo Wang, et al.. (2015). TNM Staging of Pancreatic Neuroendocrine Tumors. Medicine. 94(12). e660–e660. 33 indexed citations
13.
Zhang, Yi, Younan Chen, Jingqiu Cheng, et al.. (2014). DPP IV inhibitor suppresses STZ-induced islets injury dependent on activation of the IGFR/Akt/mTOR signaling pathways by GLP-1 in monkeys. Biochemical and Biophysical Research Communications. 456(1). 139–144. 9 indexed citations
14.
Su, Anping, Nengwen Ke, Yi Zhang, et al.. (2013). Does Modified Braun Enteroenterostomy Improve Alkaline Reflux Gastritis and Marginal Ulcer After Pancreaticoduodenectomy?. Digestive Diseases and Sciences. 58(11). 3224–3231. 4 indexed citations
15.
16.
Su, Anping, Nengwen Ke, Yi Zhang, et al.. (2013). Is laparoscopic approach for pancreatic insulinomas safe? Results of a systematic review and meta-analysis. Journal of Surgical Research. 186(1). 126–134. 31 indexed citations
17.
Su, Anping, Yi Zhang, Nengwen Ke, et al.. (2013). Triple-layer duct-to-mucosa pancreaticojejunostomy with resection of jejunal serosa decreased pancreatic fistula after pancreaticoduodenectomy. Journal of Surgical Research. 186(1). 184–191. 18 indexed citations
18.
Luo, Jian, Kathy Nguyen, Michael Chen, et al.. (2012). Evaluating insulin secretagogues in a humanized mouse model with functional human islets. Metabolism. 62(1). 90–99. 13 indexed citations
19.
Zhang, Yi, Lan Fu, Yanrong Lu, et al.. (2011). Pancreas anatomy and surgical procedure for pancreatectomy in rhesus monkeys. Journal of Medical Primatology. 40(6). 376–382. 3 indexed citations
20.
Li, Zhenjun, Zhaoda Zhang, Xubao Liu, et al.. (2010). Solid pseudopapillary tumor of the pancreas: The surgical procedures. Surgery Today. 41(1). 91–96. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emily Siegel Breakdown of academic impact, for papers by Yue Xie Breakdown of academic impact, for papers by Kristen D. Hadfield Breakdown of academic impact, for papers by Shi‐He Liu Breakdown of academic impact, for papers by Leandro M. Colli Breakdown of academic impact, for papers by Kirsty R. Greenow Breakdown of academic impact, for papers by Wenjing Yang Breakdown of academic impact, for papers by Hiroto Niizeki Breakdown of academic impact, for papers by Leizhou Xia Breakdown of academic impact, for papers by Ferdous M. Barlaskar
Rankless by CCL
2026